Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution.

[1]  E. Amankwah,et al.  Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics , 2017, Thrombosis and Haemostasis.

[2]  P. Prandoni,et al.  Duration of anticoagulation after isolated pulmonary embolism , 2016, European Respiratory Journal.

[3]  R. Yusen,et al.  Risk Stratification of Patients With Acute Symptomatic Pulmonary Embolism Based on Presence or Absence of Lower Extremity DVT: Systematic Review and Meta-analysis. , 2016, Chest.

[4]  S. Schulman,et al.  Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.

[5]  N. Magrini,et al.  The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation , 2015, PloS one.

[6]  P. Prandoni,et al.  D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. , 2014, Blood.

[7]  F. Pomero,et al.  The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature. , 2014, Thrombosis research.

[8]  G. Rennert,et al.  CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. , 2014, The American journal of medicine.

[9]  T. Perneger,et al.  Is atrial fibrillation associated with pulmonary embolism? , 2012, Journal of thrombosis and haemostasis : JTH.

[10]  G. Palareti,et al.  Isolated distal deep vein thrombosis: what we know and what we are doing , 2012, Journal of thrombosis and haemostasis : JTH.

[11]  E. Horváth-Puhó,et al.  Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis , 2011, Circulation.

[12]  K. Kröger,et al.  Pulmonary embolism in young males and females in Germany: data from the federal statistical office , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  D Bergqvist,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.

[14]  M. Galinski,et al.  Gender as a risk factor for pulmonary embolism after air travel , 2009, Thrombosis and Haemostasis.

[15]  H. Sørensen,et al.  Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. , 2009, European journal of internal medicine.

[16]  W. Ageno,et al.  Do Italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. , 2008, International Angiology.

[17]  W. Kapoor,et al.  Pulmonary embolism incidence is increasing with use of spiral computed tomography. , 2008, The American journal of medicine.

[18]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[19]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[20]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[21]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  V. Nicaud,et al.  Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. , 2001, The American journal of medicine.

[24]  M. Margaglione,et al.  Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. , 2000 .

[25]  E. Oger.  Incidence of Venous Thromboembolism: A Community-based Study in Western France , 2000, Thrombosis and Haemostasis.

[26]  L. Melton,et al.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.

[27]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[28]  L. Welin,et al.  DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE GENERAL POPULATION. THE STUDY OF MEN BORN IN 1913 , 1997 .

[29]  P. Mannucci,et al.  Low Prevalence of Factor V:Q506 in 41 Patients with Isolated Pulmonary Embolism , 1997, Thrombosis and Haemostasis.

[30]  J. Manson,et al.  A prospective study of risk factors for pulmonary embolism in women. , 1997, JAMA.

[31]  C. Giuntini,et al.  Pulmonary embolism: epidemiology. , 1995, Chest.

[32]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[33]  C J Carter,et al.  Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. , 1983, Annals of internal medicine.

[34]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[35]  S. Talbot.  Epidemiological features of Pulmonary Embolism , 1972, The British journal of clinical practice.

[36]  W. Coon,et al.  Some epidemiologic considerations of thromboembolism. , 1959, Surgery, gynecology & obstetrics.